Medicxi IV LP 13D and 13G filings for RAPT Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-01-06 09:22 am Purchase | 2024-12-27 | 13G | RAPT Therapeutics, Inc. RAPT | Medicxi IV LP | 22,352,000 16.900% | 22,352,000 (New Position) | Filing |